Inventor · disambiguated record
Cristopher Van Hout
Also filed as: VAN HOUT CRISTOPHER · VAN HOUT CRISTOPHER V
8 granted patents·4 pending applications·10 citations·filing 2010–2024
77Inventor score
Top patents by PatentIndex Score
12 records- 0188US11713461B2Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitorsREGENERON PHARMA·Filed 2020·Granted Aug 1, 2023·2 cites·15 claims
- 0287US8313932B2Polymerase inhibitor and method of using sameMOSER MICHAEL JAMES·Filed 2010·Granted Nov 20, 2012·8 cites·15 claims
- 0376US12509687B2Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitorsREGENERON PHARMA·Filed 2023·Granted Dec 30, 2025·0 cites·13 claims
- 0471US2025032529A1Treatment Of Hyperglycemia With Solute Carrier Family 39 Member 5 (SLC39A5) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0567US2023263821A1Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0666US2022323483A1Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0763US11331332B2Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitorsREGENERON PHARMA·Filed 2020·Granted May 17, 2022·0 cites·16 claims
- 0858US12083141B2Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitorsREGENERON PHARMA·Filed 2020·Granted Sep 10, 2024·0 cites·12 claims
- 0958US11504390B2Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitorsREGENERON PHARMA·Filed 2020·Granted Nov 22, 2022·0 cites·20 claims
- 1057US10738284B2B4GALT1 cDNA variants and compositions comprising the sameREGENERON PHARMA·Filed 2018·Granted Aug 11, 2020·0 cites·13 claims
- 1156US12480103B2B4GALT1 variants and uses thereofREGENERON PHARMA·Filed 2020·Granted Nov 25, 2025·0 cites·14 claims
- 1255US2022217956A1Rodent Model Of Increased Bone Mineral DensityREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cristopher Van Hout files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →